Leave Your Message

Submit An Free Inquiry

Our medical team will make an evaluation for you, based on the information you provided. This procedure is free of charge.

AI Helps Write
AI Helps Write

Khansa ya m'magazi ya Lymphoblastic (T-ALL)-03

Wodwala: Huang XX

Jenda:Mwamuna

Zaka: Zaka 42

UfuluChitchaina

Kuzindikira matenda:Acute Lymphoblastic Leukemia (T-ALL)

    Zinthu Za Mlandu:

    - Kuzindikira: Matenda a khansa ya m'magazi ya T-cell lymphoblastic

    - Kuyamba ndi Zizindikiro: Epulo 2020, adakumana ndi chizungulire, kutopa, komanso kutuluka magazi pakhungu. Adapezeka ndi khansa ya m'magazi ya T-cell lymphoblastic kudzera mu kafukufuku wa MICM wa m'mafupa.

    - Chithandizo Choyamba: Anapeza mpumulo wathunthu (CR) pambuyo pa chithandizo cha VDCLP, kenako analandira ma chemotherapy awiri amphamvu.

    - Julayi 19, 2020: Analandira allogeneic hematopoietic stem cell transplantation kuchokera kwa mkazi wopereka (HLA 5/10 A donor A). Njira yochiritsira matenda inali kuphatikizapo kuunikira thupi lonse (TBI), cyclophosphamide (CY), ndi etoposide (VP-16). Maselo oyambira a m'mphepete mwa thupi adalowetsedwa pa Julayi 24, ndi kuchira kwa granulocyte pofika tsiku +10 ndi kulowetsedwa kwa ma platelet pofika tsiku +13. Kutsatira nthawi zonse kwa odwala omwe akupita kuchipatala pambuyo pake.

    - February 25, 2021: Kubwereranso kwa mafuta m'mafupa kunapezeka panthawi yotsatiridwa.

    - Chithandizo: Ndinayamba kumwa mankhwala a thalidomide.

    - Marichi 8: Analowa m'chipatala chathu.

    - Maonekedwe a Bone Bone Morophology: 61.5% ya kuphulika.

    - Kugawa Magazi Ozungulira: 15% ya kuphulika.

    - Immunophenotyping: 35.25% ya maselo omwe ali ndi CD99, CD5, CD3dim, CD8dim, CD7, cCD3, CD2dim, HLA-ABC, cbcl-2, CD81, CD38, zomwe zikusonyeza ma T lymphocytes osakhwima omwe ali ndi khansa.

    - Kusanthula kwa Chromosome: 46, XX [9].

    - Leukemia Fusion Gene: SIL-TAL1 fusion gene positive; muyeso wochuluka: SIL-TA.

    - Kusintha kwa Chotupa cha M'magazi: Choyipa.

    - Kusanthula kwa Chimerism (pambuyo pa HSCT): Maselo otengedwa ndi opereka anali 45.78%.

    - Marichi 11: Kusonkhanitsa ma lymphocyte a magazi a autologous kuti apeze maselo a CD7-CART.

    - Chithandizo: Mankhwala a VILP (VDS 4mg, IDA 10mg, L-asparaginase 10,000 IU qd x masiku 4, Dex 9mg q12h x masiku 9) ophatikizidwa ndi thalidomide kuti athetse chotupacho.

    - Marichi 19: Chithandizo cha mankhwala a FC regimen (Flu 50mg x masiku atatu, CTX 0.4gx masiku atatu).

    - Marichi 24 (asanalowetsedwe): Kapangidwe ka mafupa a m'mafupa kanasonyeza kuchuluka kwa shuga m'magazi (grade V hyperplasia), ndipo 22% ya kuphulika kwake inali yofanana.

    - Kuchuluka kwa Marrow Flow Cytometry: 29.21% ya maselo (a maselo okhala ndi nucleotide) omwe amatulutsa CD3, CD5, CD7, CD99, omwe amatulutsa pang'ono cCD3, zomwe zikusonyeza maselo a T osakhwima omwe ali ndi khansa.

    - Chiwerengero cha SIL-TAL1 Fusion Gene: 1.913%.

    25dho

    Chithandizo:
    - Marichi 26: Kulowetsedwa kwa maselo a autologous CD7-CART (5*10^5/kg)
    - Zotsatira Zokhudzana ndi CAR-T: CRS giredi 1 (malungo), palibe poizoni wa mitsempha
    - Epulo 12 (Tsiku 17): Kutsatira kunawonetsa mawonekedwe a mafupa a m'mafupa mu relieval, palibe maselo osakhwima omwe amapezeka ndi flow cytometry, ndi kuchuluka kwa majini a SIL-TAL1 (STIL-SCL) fusion pa 0

    26i6g

    kufotokozera2

    Submit An Free Inquiry

    Our medical team will make an evaluation for you, based on the information you provided. This procedure is free of charge.

    AI Helps Write